Improving active surveillance for men with low-risk prostate cancer
Official title: Planning to implement high-quality active surveillance in new-onset favorable risk prostate cancer
Funded at University of Missouri-Columbia · NIH-10869475 · Data updated 2026-11-12
This study is looking to help men with low-risk prostate cancer by making sure they get the right kind of monitoring, so they can avoid unnecessary treatments and side effects, and it involves working with urologists in Michigan to improve care for these patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Missouri-Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project start | September 13, 2024 |
| Project end | November 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $327,496 |
| NIH project number | 1R34CA283349-01A1 |
| Project ID | NIH-10869475 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are men diagnosed with favorable-risk prostate cancer who are considering active surveillance as a treatment option.
✕Less likely to help
Patients with aggressive forms of prostate cancer or those requiring immediate intervention may not benefit from this research.
What this research studies
This research focuses on enhancing the implementation of active surveillance for men diagnosed with favorable-risk prostate cancer, which is a less aggressive form of the disease. The study aims to identify patients with indolent tumors and ensure they are monitored effectively to prevent unnecessary treatment and its associated side effects. By utilizing confirmatory testing methods like prostate biopsy or MRI within six months of diagnosis, the research seeks to improve the accuracy of patient selection for surveillance. The project is being conducted in collaboration with a large network of urologists in Michigan, aiming to standardize and improve the quality of care for these patients.
Why it matters
Potential benefit: If successful, this research could lead to better management of low-risk prostate cancer, reducing unnecessary treatments and improving patient quality of life.
How similar studies have gone: Previous research has shown that improving monitoring and adherence to active surveillance protocols can enhance patient outcomes, indicating that this approach has potential for success.
Where this research is happening
-
University of Missouri-Columbia
Columbia, United States Active
Researchers
- Principal investigator: Sales, Anne Evelyn — University of Missouri-Columbia
- Study coordinator: Sales, Anne Evelyn
Related research
Other NIH-funded projects on the same topics.
-
Cardiovascular risk planning and reduction for men with prostate cancer
A program to better predict and reduce heart disease risk in men treated for prostate cancer, especially older patients.
-
Effects of ADT on motivation and emotion in prostate cancer patients
This project looks at how androgen deprivation therapy may affect motivation and mood over time in men with prostate cancer.
-
Causal Protein Markers to Understand and Predict Prostate Cancer Risk in Africans and Europeans
A cancer research project looking at proteins linked to prostate cancer to better understand why it happens and how risk differs between African and European populations.
-
Ethical multimodal AI platform to improve prostate cancer detection with ultrasound
A patient-friendly AI system uses ultrasound and MRI information to help doctors better find prostate cancer, aiming to improve accuracy and access.
-
Characterizing epigenetic targets in prostate cancer to help AR-driven cancer
A research project at MD Anderson aims to understand how epigenetic factors shape androgen receptor signaling in prostate cancer to find new ways to treat resistant forms of the disease.
-
AR and RNA-binding in prostate cancer resistance
A cancer research grant exploring how the androgen receptor’s interaction with RNA may drive treatment resistance in prostate cancer, with potential to guide new therapies.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.